TrialRheumatology (Oxford, England)2025

Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate.

Maya H Buch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.